Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.

Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q34527748
The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?Immunoregulatory functions of VISTA.Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles.Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non-small cell lung cancer.The immune checkpoint molecule VISTA regulates allergen-specific Th2-mediated immune responses.The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy.Not All Immune Checkpoints Are Created Equal
P2860

Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q34527748
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Differential contribution of t ...... ainst squamous cell carcinoma.
@ast
Differential contribution of t ...... ainst squamous cell carcinoma.
@en
Differential contribution of t ...... ainst squamous cell carcinoma.
@nl
type
label
Differential contribution of t ...... ainst squamous cell carcinoma.
@ast
Differential contribution of t ...... ainst squamous cell carcinoma.
@en
Differential contribution of t ...... ainst squamous cell carcinoma.
@nl
prefLabel
Differential contribution of t ...... ainst squamous cell carcinoma.
@ast
Differential contribution of t ...... ainst squamous cell carcinoma.
@en
Differential contribution of t ...... ainst squamous cell carcinoma.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P478
P577
P698
P356
P1433
P1476
Differential contribution of t ...... ainst squamous cell carcinoma.
@en
P2093
P304
P31
P356
10.1016/J.ORALONCOLOGY.2016.04.005
P407
P478
P577
P698